T-cell prolymphocytic leukemia

出典: meddic

T細胞性前リンパ球性白血病T細胞性前リンパ性白血病

chronic lymphocytic leukemia、chronic T-cell leukemia、T-cell prolymphocytic leukaemiaT-PLL


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/01/11 21:59:42」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

英文文献

  • Primary Refractory T-cell prolymphocytic leukaemia treated with Daily Administration of Alemtuzumab plus high dose methylprednisolone.
  • Renaudon-Smith E, Gribben JG, Agrawal SG.Author information Division of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.AbstractT cell prolymphocytic leukemia (T-PLL) is a rare lymphoproliferative disorder associated with an aggressive course and a poor response to conventional chemotherapy, with a median survival of 7.5.months1 . Non-chemotherapy treatment with the anti-CD52 monoclonal antibody, Alemtuzumab, is effective in the management of this condition, producing complete remissions in 81% of patients as first line treatment and 60% following relapse/refractoriness to other therapies2 . Currently there is no clear consensus in the literature about how to proceed in the setting of refractoriness to Alemtuzumab. One group has suggested that Pentostatin (a purine analogue) may be added, although this was in the setting of subcutaneous Alemtuzumab based on their prior experience with this as a single agent1 . This article is protected by copyright. All rights reserved.
  • European journal of haematology.Eur J Haematol.2013 Dec 14. doi: 10.1111/ejh.12248. [Epub ahead of print]
  • T cell prolymphocytic leukemia (T-PLL) is a rare lymphoproliferative disorder associated with an aggressive course and a poor response to conventional chemotherapy, with a median survival of 7.5.months1 . Non-chemotherapy treatment with the anti-CD52 monoclonal antibody, Alemtuzumab, is effective in
  • PMID 24329558
  • Minimal change disease in graft versus host disease: a podocyte response to the graft?
  • Huskey J, Rivard C, Myint H, Lucia S, Smith M, Shimada M, Ishimoto T, Araya C, Garin EH, Johnson RJ.AbstractNephrotic syndrome is a rare complication of hematopoietic cell transplantation. It has been suggested that nephrotic syndrome may represent a limited form of graft-versus-host disease although the pathological link between these two entities remains unclear. In this paper, we report a case of a 61-year-old female who underwent nonmyeloablative allogenic stem cell transplantation for T-cell prolymphocytic leukemia and subsequently developed biopsy proven minimal change disease shortly after cessation of her immunosuppression therapy. Urinary CD80 was markedly elevated during active disease and disappeared following corticosteroid-induced remission. We hypothesize that alloreactive donor T cells target the kidney and induce podocyte expression of CD80 that results in proteinuria from limited 'graft versus host' disease.
  • Clinical nephrology.Clin Nephrol.2013 Dec;80(6):469-73. doi: 10.5414/CN107420.
  • Nephrotic syndrome is a rare complication of hematopoietic cell transplantation. It has been suggested that nephrotic syndrome may represent a limited form of graft-versus-host disease although the pathological link between these two entities remains unclear. In this paper, we report a case of a 61-
  • PMID 23006339
  • Immunophenotypic characterization of T-cell prolymphocytic leukemia.
  • Chen X, Cherian S.Author information Dept of Laboratory Medicine, University of Washington, 1959 NE Pacific St, Seattle, WA 98195; xchen1@u.washington.edu.AbstractOBJECTIVES: To review clinical data, cytogenetic findings, and flow cytometric analysis in 20 patients with T-cell prolymphocytic leukemia (T-PLL), a rare, aggressive, mature T-cell leukemia with poor prognosis and short survival.
  • American journal of clinical pathology.Am J Clin Pathol.2013 Nov;140(5):727-35. doi: 10.1309/AJCPG71KYOXTKLQW.
  • OBJECTIVES: To review clinical data, cytogenetic findings, and flow cytometric analysis in 20 patients with T-cell prolymphocytic leukemia (T-PLL), a rare, aggressive, mature T-cell leukemia with poor prognosis and short survival.METHODS: Using multiparameter flow cytometry with a large combination
  • PMID 24124154

和文文献

  • T-cell prolymphocytic leukemia in Japan : is it a variant?
  • KAMEOKA Junichi,TAKAHASHI Naoto,NOJI Hideyoshi,MURAI Kazunori,TAJIMA Katsushi,KAMEOKA Yoshihiro,SATO Shinji,SHICHISHIMA Tsutomu,ISHIDA Yoji,HARIGAE Hideo,SAWADA Kenichi
  • International journal of hematology 95(6), 660-667, 2012-06-01
  • NAID 10030793639
  • Epstein-Barr Virus-Negative Classical Hodgkin's Lymphoma in a Patient with T-Cell Prolymphocytic Leukemia Treated with Fludarabine
  • TSUJI Takahiro,YAMASAKI Hiroshi,ARIMA Nobuyuki,NIINO Daisuke,OHSHIMA Koichi,TSUDA Hiroyuki
  • Journal of clinical and experimental hematopathology 52(1), 71-75, 2012-05-01
  • NAID 10030615686
  • TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients
  • YOKOHAMA Akihiko,SAITOH Akio,NAKAHASHI Hirotaka,MITSUI Takeki,KOISO Hiromi,KIM Yoshitora,UCHIUMI Hideki,SAITOH Takayuki,HANDA Hiroshi,JIMBO Takahiro,MURAYAMA Kayoko,SAKURA Tohru,MURAKAMI Hirokazu,KARASAWA Masamitsu,NOJIMA Yoshihisa,TSUKAMOTO Norifumi
  • International journal of hematology 95(1), 77-85, 2012-01-01
  • NAID 10030266898

関連リンク

T-cell prolymphocytic leukemia is a rare and unusual malignancy characterized by the proliferation of small- to medium-sized prolymphocytes of postthymic origin with distinctive clinical, morphologic, immunophenotypic ...
T-cell prolymphocytic leukemia (T-PLL), also known as T-cell chronic lymphocytic leukemia, T-prolymphocytic leukemia and T-cell lymphocytic leukemia, is a rare form of T-cell leukemia (a subtype of chronic lymphocytic leukemia ...

関連画像

cell prolymphocytic leukemia - 3.cell prolymphocytic leukemia - 2.Prolymphocytic Leukemia T-prolymphocytic  Leukemia T-cell prolymphocytic leukemiacell prolymphocytic leukemia - 3.prolymphocytic leukemia - 4.


★リンクテーブル★
先読みchronic lymphocytic leukemia
リンク元T細胞性前リンパ性白血病」「T細胞性前リンパ球性白血病」「T-cell prolymphocytic leukaemia」「T-PLL
関連記事cell」「leukemia」「T」「Ted」「prolymphocytic

chronic lymphocytic leukemia」

  [★] 慢性リンパ性白血病 CLL


T細胞性前リンパ性白血病」

  [★]

T-cell prolymphocytic leukemia、((古))T-cell prolymphocytic leukaemia
慢性T細胞性白血病、T細胞性前リンパ球性白血病

T細胞性前リンパ球性白血病」

  [★]

T-cell prolymphocytic leukemia、((古))T-cell prolymphocytic leukaemia、T-PLL
T細胞性前リンパ性白血病


T-cell prolymphocytic leukaemia」

  [★]

T細胞性前リンパ球性白血病T細胞性前リンパ性白血病

T-cell prolymphocytic leukemiaT-PLL


T-PLL」

  [★]

T-cell prolymphocytic leukaemiaT-cell prolymphocytic leukemia


cell」

  [★] 細胞

WordNet   license wordnet

「small room in which a monk or nun lives」
cubicle

WordNet   license wordnet

「a device that delivers an electric current as the result of a chemical reaction」
electric cell

WordNet   license wordnet

「a room where a prisoner is kept」
jail cell, prison cell

WordNet   license wordnet

「(biology) the basic structural and functional unit of all organisms; they may exist as independent units of life (as in monads) or may form colonies or tissues as in higher plants and animals」

WordNet   license wordnet

「any small compartment; "the cells of a honeycomb"」

WordNet   license wordnet

「a small unit serving as part of or as the nucleus of a larger political movement」
cadre

PrepTutorEJDIC   license prepejdic

「(刑務所の)『独房』;(修道院の)小さい独居室 / (ミツバチの)みつ房,巣穴 / 小さい部屋 / 『細胞』 / 電池 / 花粉室 / (共産党などの)細胞」


leukemia」

  [★] 白血病

WordNet   license wordnet

「malignant neoplasm of blood-forming tissues; characterized by abnormal proliferation of leukocytes; one of the four major types of cancer」
leukaemia, leucaemia, cancer of the blood

PrepTutorEJDIC   license prepejdic

「白血病」


T」

  [★]


WordNet   license wordnet

「the 20th letter of the Roman alphabet」
t

PrepTutorEJDIC   license prepejdic

「tritiumの化学記号」


Ted」

  [★]

WordNet   license wordnet

「a tough youth of 1950''s and 1960''s wearing Edwardian style clothes」
Teddy boy


prolymphocytic」

  [★]

  • 前リンパ球性の、前リンパ性の




★コメント★

[メモ入力エリア]
※コメント5000文字まで
ニックネーム:
コメント:




表示
個人用ツール


  meddic.jp

リンク
連絡